Frontline science: myeloid-derived suppressor cells (MDSCS) facilitate maternal–fetal tolerance in mice

Journal of Leukocyte Biology

Volumn 101, Issue 5, 2017, Pages 1091-1101

  Ostrand Rosenberg, Suzanne ^a   Sinha, Pratima ^a   Figley, Chas ^a   Long, Ramses ^a   Park, DoHwan ^a   Carter, Darryl ^b   Clements, Virginia K ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^b Nora Therapeutics Inc   (United States)

Author keywords

G CSF; Immune suppression; Implantation; Myeloid cells; Pregnancy; T cell activation

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERLEUKIN 2; L SELECTIN; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CIRCULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; LYMPH NODE; LYMPHOCYTIC INFILTRATION; MALE; MATING; MONOCYTE; MOTHER FETUS RELATIONSHIP; MOUSE; MYELOID-DERIVED SUPPRESSOR CELL; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; UTERUS; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL COMMUNICATION; CELL COUNT; CYTOLOGY; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MAMMALIAN EMBRYO; NIDATION; PREGNANCY; T LYMPHOCYTE;

ANIMALS; CELL COMMUNICATION; CELL COUNT; EMBRYO IMPLANTATION; EMBRYO, MAMMALIAN; FEMALE; HISTOCOMPATIBILITY, MATERNAL-FETAL; HUMANS; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYELOID-DERIVED SUPPRESSOR CELLS; PREGNANCY; T-LYMPHOCYTES;

EID: 85018429905     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1HI1016-306RR     Document Type: Article

References (60)

1. Medawar, P. B. (1961) Immunological tolerance. Science 133, 303–306.
2. Erlebacher, A. (2013) Mechanisms of T cell tolerance towards the allogeneic fetus. Nat. Rev. Immunol. 13, 23–33.
3. +)CD25high regulatory T cells in human pregnancy. J. Reprod. Immunol. 65, 111–120.
4. Jasper, M. J., Tremellen, K. P., Robertson, S. A. (2006) Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol. Hum. Reprod. 12, 301–308.
5. Jiang, T. T., Chaturvedi, V., Ertelt, J. M., Kinder, J. M., Clark, D. R., Valent, A. M., Xin, L., Way, S. S. (2014) Regulatory T cells: new keys for further unlocking the enigma of fetal tolerance and pregnancy complications. J. Immunol. 192, 4949–4956.
6. Inada, K., Shima, T., Nakashima, A., Aoki, K., Ito, M., Saito, S. (2013) Characterization of regulatory T cells in decidua of miscarriage cases with abnormal or normal fetal chromosomal content. J. Reprod. Immunol. 97, 104–111.
7. Aluvihare, V. R., Kallikourdis, M., Betz, A. G. (2004) Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5, 266–271.
8. + regulatory/suppressor T cells prevent allogeneic fetus rejection in mice[published correction in Immunol. Lett. (2006) 102, 241].. Immunol. Lett. 102, 106–109.
9. + T regulatory cells prevents fetal rejection in a murine abortion model. Am. J. Pathol. 166, 811–822.
10. Nancy, P., Tagliani, E., Tay, C. S., Asp, P., Levy, D. E., Erlebacher, A. (2012) Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science 336, 1317–1321.
11. Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., Mellor, A. L. (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191–1193.
12. Köstlin, N., Hofstädter, K., Ostermeir, A. L., Spring, B., Leiber, A., Haen, S., Abele, H., Bauer, P., Pollheimer, J., Hartl, D., Poets, C. F., Gille, C. (2016) Granulocytic myeloid-derived suppressor cells accumulate in human placenta and polarize toward a Th2 phenotype. J. Immunol. 196, 1132–1145.
13. Piccinni, M. P., Beloni, L., Livi, C., Maggi, E., Scarselli, G., Romagnani, S. (1998) Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat. Med. 4, 1020–1024.
14. + regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol. Reprod. 82, 698–705.
15. Gabrilovich, D. I., Ostrand-Rosenberg, S., Bronte, V. (2012) Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253–268.
16. Gabrilovich, D. I., Bronte, V., Chen, S. H., Colombo, M. P., Ochoa, A., Ostrand-Rosenberg, S., Schreiber, H. (2007) The terminology issue for myeloid-derived suppressor cells. Cancer Res. 67, 425, author reply 426.
17. Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., Gabrilovich, D. I. (2001) Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166, 678–689.
18. Bunt, S. K., Sinha, P., Clements, V. K., Leips, J., Ostrand-Rosenberg, S. (2006) Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J. Immunol. 176, 284–290.
19. Bunt, S. K., Yang, L., Sinha, P., Clements, V. K., Leips, J., Ostrand-Rosenberg, S. (2007) Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 67, 10019–10026.
20. Sander, L. E., Sackett, S. D., Dierssen, U., Beraza, N., Linke, R. P., Müller, M., Blander, J. M., Tacke, F., Trautwein, C. (2010) Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207, 1453–1464.
21. Lees, J. R., Azimzadeh, A. M., Bromberg, J. S. (2011) Myeloid derived suppressor cells in transplantation. Curr. Opin. Immunol. 23, 692–697.
22. Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N., Bicciato, S., Falisi, E., Calabrese, F., Basso, G., Zanovello, P., Cozzi, E., Mandruzzato, S., Bronte, V. (2010) Tumor-induced tolerance and immune suppression depend on the C/EBPb transcription factor. Immunity 32, 790–802.
23. Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., Antonia, S., Ochoa, J. B., Ochoa, A. C. (2004) Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 64, 5839–5849.
24. Corzo, C. A., Cotter, M. J., Cheng, P., Cheng, F., Kusmartsev, S., Sotomayor, E., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., Gabrilovich, D. I. (2009) Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol. 182, 5693–5701.
25. Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P., Ostrand-Rosenberg, S. (2010) Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 70, 68–77.
26. + T cells. J. Immunol. 183, 937–944.
27. Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., Ostrand-Rosenberg, S. (2007) Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 179, 977–983.
28. + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66, 1123–1131.
29. Shojaei, F., Wu, X., Qu, X., Kowanetz, M., Yu, L., Tan, M., Meng, Y. G., Ferrara, N. (2009) G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proc. Natl. Acad. Sci. USA 106, 6742–6747.
30. Boelte, K. C., Gordy, L. E., Joyce, S., Thompson, M. A., Yang, L., Lin, P. C. (2011) Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1. PLoS One 6, e18534.
31. + cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6, 409–421.
32. 2 T cells by activation of the TGF-b/b-catenin pathway. Mol. Hum. Reprod. 22, 499–511.
33. Zhao, H., Kalish, F., Schulz, S., Yang, Y., Wong, R. J., Stevenson, D. K. (2015) Unique roles of infiltrating myeloid cells in the murine uterus during early to midpregnancy. J. Immunol. 194, 3713–3722.
34. Nair, R., Sinha, P., Khanna, A., Singh, K. (2015) Reduced myeloid-derived supperssor cells in the blood and endometrium is associated with early miscarriage. Am. J. Reprod. Immunol. 73, 479–486.
35. Kropf, P., Baud, D., Marshall, S. E., Munder, M., Mosley, A., Fuentes, J. M., Bangham, C. R., Taylor, G. P., Herath, S., Choi, B. S., Soler, G., Teoh, T., Modolell, M., Müller, I. (2007) Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur. J. Immunol. 37, 935–945.
36. He, Y. Y., Du, M. R., Guo, P. F., He, X. J., Zhou, W. H., Zhu, X. Y., Li, D. J. (2007) Regulation of C-C motif chemokine ligand 2 and its receptor in human decidual stromal cells by pregnancy-associated hormones in early gestation. Hum. Reprod. 22, 2733–2742.
37. Lesokhin, A. M., Hohl, T. M., Kitano, S., Cortez, C., Hirschhorn-Cymerman, D., Avogadri, F., Rizzuto, G. A., Lazarus, J. J., Pamer, E. G., Houghton, A. N., Merghoub, T., Wolchok, J. D. (2012) Monocytic CCR2 myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment. Cancer Res. 72, 876–886.
38. Waight, J. D., Hu, Q., Miller, A., Liu, S., Abrams, S. I. (2011) Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS One 6, e27690.
39. Santjohanser, C., Knieper, C., Franz, C., Hirv, K., Meri, O., Schleyer, M., Würfel, W., Toth, B. (2013) Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage. Arch. Immunol. Ther. Exp. (Warsz.) 61, 159–164.
40. Scarpellini, F., Sbracia, M. (2009) Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum. Reprod. 24, 2703–2708.
41. Albaghdadi, A. J., Kan, F. W. (2012) Endometrial receptivity defects and impaired implantation in diabetic NOD mice. Biol. Reprod. 87, 30.
42. Nakamura, H., Kimura, T., Koyama, S., Ogita, K., Tsutsui, T., Shimoya, K., Taniguchi, T., Koyama, M., Kaneda, Y., Murata, Y. (2006) Mouse model of human infertility: transient and local inhibition of endometrial STAT-3 activation results in implantation failure. FEBS Lett. 580, 2717–2722.
43. Sinha, P., Clements, V. K., Ostrand-Rosenberg, S. (2005) Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J. Immunol. 174, 636–645.
44. Bronte, V., Brandau, S., Chen, S. H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., Rodriguez, P. C., Sica, A., Umansky, V., Vonderheide, R. H., Gabrilovich, D. I. (2016) Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat. Commun. 7, 12150.
45. http://jaxmice.jax.org/jaxnotes/archive/501d.html.
46. Smith, C., Chang, M. Y., Parker, K. H., Beury, D. W., DuHadaway, J. B., Flick, H. E., Boulden, J., Sutanto-Ward, E., Soler, A. P., Laury-Kleintop, L. D., Mandik-Nayak, L., Metz, R., Ostrand-Rosenberg, S., Prendergast, G. C., Muller, A. J. (2012) IDO is a nodal pathogenic driver of lung cancer and metastasis development. Cancer Discov. 2, 722–735.
47. Luyckx, A., Schouppe, E., Rutgeerts, O., Lenaerts, C., Fevery, S., Devos, T., Dierickx, D., Waer, M., Van Ginderachter, J. A., Billiau, A. D. (2012) G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells. Clin. Immunol. 143, 83–87.
48. Bulmer, J. N., Williams, P. J., Lash, G. E. (2010) Immune cells in the placental bed. Int. J. Dev. Biol. 54, 281–294.
49. Mauti, L. A., Le Bitoux, M. A., Baumer, K., Stehle, J. C., Golshayan, D., Provero, P., Stamenkovic, I. (2011) Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation. J. Clin. Invest. 121, 2794–2807.
50. Huang, B., Lei, Z., Zhao, J., Gong, W., Liu, J., Chen, Z., Liu, Y., Li, D., Yuan, Y., Zhang, G. M., Feng, Z. H. (2007) CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Cancer Lett. 252, 86–92.
51. Sade-Feldman, M., Kanterman, J., Ish-Shalom, E., Elnekave, M., Horwitz, E., Baniyash, M. (2013) Tumor necrosis factor-a blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 38, 541–554.
52. Sinha, P., Clements, V. K., Fulton, A. M., Ostrand-Rosenberg, S. (2007) Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res. 67, 4507–4513.
53. Serafini, P., Mgebroff, S., Noonan, K., Borrello, I. (2008) Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 68, 5439–5449.
54. Yu, J., Du, W., Yan, F., Wang, Y., Li, H., Cao, S., Yu, W., Shen, C., Liu, J., Ren, X. (2013) Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. J. Immunol. 190, 3783–3797.
55. Chung, D. J., Rossi, M., Romano, E., Ghith, J., Yuan, J., Munn, D. H., Young, J. W. (2009) Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 114, 555–563.
56. + regulatory T cells: differentiation, specification, subphenotypes. Nat. Immunol. 10, 689–695.
57. Conejo-Garcia, J. R., Rutkowski, M. R., Cubillos-Ruiz, J. R. (2016) State-of-the-art of regulatory dendritic cells in cancer. Pharmacol. Ther. 164, 97–104.
58. Ostrand-Rosenberg, S. (1980) Cell-mediated immune responses to mouse embryonic cells: detection and characterization of embryonic antigens. Curr. Top. Dev. Biol. 14, 147–168.
59. Kahn, D. A., Baltimore, D. (2010) Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance. Proc. Natl. Acad. Sci. USA 107, 9299–9304.
60. Poschke, I., Mao, Y., Adamson, L., Salazar-Onfray, F., Masucci, G., Kiessling, R. (2012) Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines. Cancer Immunol. Immunother. 61, 827–838.